000 01210 a2200361 4500
005 20250511211207.0
264 0 _c19910924
008 199109s 0 0 eng d
022 _a0195-668X
024 7 _a10.1093/oxfordjournals.eurheartj.a059953
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIbáñez, L
245 0 0 _aAgranulocytosis associated with aprindine and other antiarrhythmic drugs: an epidemiological approach.
_h[electronic resource]
260 _bEuropean heart journal
_cMay 1991
300 _a639-41 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAged
650 0 4 _aAgranulocytosis
_xchemically induced
650 0 4 _aAnti-Arrhythmia Agents
_xadverse effects
650 0 4 _aAprindine
_xadverse effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRetrospective Studies
650 0 4 _aRisk Factors
700 1 _aJuan, J
700 1 _aPérez, E
700 1 _aCarné, X
700 1 _aLaporte, J R
773 0 _tEuropean heart journal
_gvol. 12
_gno. 5
_gp. 639-41
856 4 0 _uhttps://doi.org/10.1093/oxfordjournals.eurheartj.a059953
_zAvailable from publisher's website
999 _c1880467
_d1880467